Invokamet 50mg/1000mg Tablets
Overview
What is this medicine?
How to Use This Medicine
To use this medication correctly, follow your doctor's instructions and read all the information provided. Take your medication with meals as directed. It's also important to drink plenty of non-caffeinated liquids, unless your doctor advises you to limit your fluid intake.
Continue taking your medication as prescribed by your doctor or healthcare provider, even if you start to feel better. This will help ensure that you receive the full benefits of the treatment.
Storing and Disposing of Your Medication
To maintain the quality and safety of your medication, store it in its original container at room temperature. Keep it in a dry place, away from the bathroom. If you need to store your medication outside of its original container, be sure to discard any unused portion after 30 days.
What to Do If You Miss a Dose
If you miss a dose, take it as soon as you remember. However, if it's close to the time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule. Do not take two doses at the same time or take extra doses to make up for the missed one.
Lifestyle & Tips
- Take Invokamet exactly as prescribed by your doctor, usually twice a day with meals to reduce stomach upset from metformin.
- Maintain a healthy diet as recommended by your doctor or dietitian.
- Engage in regular physical activity as advised by your healthcare provider.
- Stay well-hydrated by drinking plenty of fluids, especially when exercising or in hot weather, to reduce the risk of dehydration and kidney problems.
- Monitor your blood sugar levels regularly as instructed by your doctor.
- Carry a source of sugar (e.g., glucose tablets, hard candy) to treat mild hypoglycemia if you are also taking insulin or a sulfonylurea.
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Canagliflozin: Inhibits SGLT2 in the renal proximal tubules, reducing glucose reabsorption and increasing urinary glucose excretion, thereby lowering plasma glucose concentrations.
Metformin: Decreases hepatic glucose production, decreases intestinal absorption of glucose, and improves insulin sensitivity by increasing peripheral glucose uptake and utilization.
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
BLACK BOX WARNING
Side Effects
Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following signs or symptoms, contact your doctor immediately or seek emergency medical attention:
Allergic Reaction: Rash, hives, itching, red, swollen, blistered, or peeling skin with or without fever, wheezing, tightness in the chest or throat, trouble breathing, swallowing, or talking, unusual hoarseness, or swelling of the mouth, face, lips, tongue, or throat.
Fluid and Electrolyte Problems: Mood changes, confusion, muscle pain or weakness, fast or abnormal heartbeat, severe dizziness or passing out, increased thirst, seizures, feeling very tired or weak, decreased appetite, unable to pass urine or change in the amount of urine produced, dry mouth, dry eyes, or severe upset stomach or vomiting.
Urinary Tract Infection (UTI): Blood in the urine, burning or pain when passing urine, feeling the need to pass urine often or right away, fever, lower stomach pain, or pelvic pain.
Kidney Problems: Unable to pass urine, change in how much urine is passed, blood in the urine, or a significant weight gain.
Vaginal Yeast Infection: Itching, bad odor, or discharge. Report these symptoms to your doctor.
Yeast Infection of the Penis: Pain, swelling, rash, or discharge. Report these symptoms to your doctor.
Bone Pain: Notify your doctor if you experience bone pain.
Low Blood Sugar: This medication may increase the risk of low blood sugar, especially when used with other diabetes medications. Signs of low blood sugar include dizziness, headache, feeling sleepy or weak, shaking, fast heartbeat, confusion, hunger, or sweating. If you experience any of these symptoms, contact your doctor immediately and follow their instructions for managing low blood sugar, which may include taking glucose tablets, liquid glucose, or some fruit juices.
Stomach Problems: While stomach problems like upset stomach, vomiting, or diarrhea are common when starting this medication, if you experience these symptoms later during treatment, contact your doctor right away, as they may be a sign of a serious condition called lactic acidosis.
Rare but Serious Infection: A rare but potentially life-threatening infection has been reported with medications like this one. Seek medical help immediately if your genitals or the area between your genitals and rectum becomes tender, red, or swollen, and you have a fever or do not feel well.
Increased Risk of Lower Limb Amputations: This medication may increase the risk of lower limb amputations, particularly toe and foot amputations. Discuss foot care with your doctor, and notify them if you have a history of amputation, blood vessel disease, nerve disease, or a foot ulcer caused by diabetes. Contact your doctor right away if you experience new pain or tenderness, sores or ulcers, or infections in your legs or feet.
Other Possible Side Effects
While not everyone experiences side effects, some people may have mild or moderate side effects. If you experience any of the following side effects or any other symptoms that bother you or do not go away, contact your doctor:
Passing urine more often
Gas
Stomach pain or heartburn
Diarrhea, upset stomach, or vomiting
Headache
* Feeling tired or weak
This is not a comprehensive list of all possible side effects. If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- **Lactic Acidosis (Medical Emergency):** Unusual muscle pain, trouble breathing, stomach pain, dizziness, lightheadedness, feeling cold, very tired or weak. Seek immediate medical attention.
- **Diabetic Ketoacidosis (DKA):** Nausea, vomiting, stomach pain, excessive thirst, rapid deep breathing, unusual sleepiness, fruity breath odor. Seek immediate medical attention.
- **Dehydration/Volume Depletion:** Dizziness, lightheadedness, fainting, especially when standing up.
- **Kidney Problems:** Decreased urination, swelling in your legs or feet.
- **Urinary Tract Infections (UTIs):** Burning sensation when urinating, frequent urination, urgent need to urinate, pain in the lower stomach or pelvis, fever, back pain.
- **Genital Yeast Infections:** Itching, redness, swelling, or discharge in the genital area.
- **Fournier's Gangrene (Rare but Serious):** Pain, tenderness, redness, or swelling in the genital or perineal area, accompanied by fever or malaise. Seek immediate medical attention.
- **Lower Limb Amputation (Rare):** New pain, tenderness, sores, ulcers, or infections in the legs or feet. Report these symptoms to your doctor immediately.
Before Using This Medicine
It is essential to inform your doctor about the following:
Any allergies you have, including allergies to this medication, its components, or other substances. Be sure to describe the allergic reaction you experienced, including any symptoms that occurred.
Certain health conditions, such as:
+ Acidic blood problems
+ Kidney disease
+ Liver disease
+ Type 1 diabetes
Recent heart attack or stroke
Any difficulties with eating or drinking, including situations where you may be required to fast before a procedure or surgery
Upcoming or recent exams or tests that involve contrast agents (within the past 48 hours)
Additionally, if you are:
Pregnant or think you may be pregnant. Do not take this medication during the second or third trimester of pregnancy.
* Breast-feeding. You should not breast-feed while taking this medication.
This list is not exhaustive, and it is crucial to discuss all your medications (prescription, over-the-counter, natural products, and vitamins) and health problems with your doctor and pharmacist. They will help determine if it is safe to take this medication with your other medications and health conditions. Never start, stop, or change the dose of any medication without first consulting your doctor.
Precautions & Cautions
To ensure your safety, avoid driving if you have experienced low blood sugar, as it increases the risk of accidents. To minimize the risk of dizziness or fainting, rise slowly from a sitting or lying down position, and exercise caution when climbing stairs. Adhere to the diet and exercise plan recommended by your doctor.
If you are following a low-salt or salt-free diet, consult with your doctor to discuss any necessary adjustments. Regularly undergo blood work and other laboratory tests as directed by your doctor, and monitor your blood sugar levels according to their instructions. Your doctor can recommend the most suitable glucose tests for you to use.
Be aware that this medication may affect the results of certain laboratory tests. Inform all your healthcare providers and laboratory personnel that you are taking this drug. Before consuming alcohol, consult with your doctor to discuss any potential risks.
High cholesterol has been associated with this medication. If you have concerns, discuss them with your doctor. In hot weather or during physical activity, drink plenty of fluids to prevent dehydration. If you are unable to consume liquids orally or experience persistent stomach upset, vomiting, or diarrhea, contact your doctor for guidance on preventing dehydration, which can lead to low blood pressure or worsen kidney problems.
During periods of stress, such as fever, infection, injury, or surgery, it may be more challenging to control your blood sugar levels. Changes in physical activity, exercise, or diet can also impact your blood sugar levels.
Long-term treatment with metformin may lead to low vitamin B-12 levels. If you have a history of low vitamin B-12 levels, consult with your doctor. A rare but serious condition called ketoacidosis (too much acid in the blood or urine) has been associated with this medication. This condition can be life-threatening and may require hospitalization. People with diabetes or pancreas problems, as well as those who are sick, dehydrated, or have undergone surgery, are at a higher risk of developing ketoacidosis. Additionally, individuals who follow a ketogenic diet, skip meals, or take less than their prescribed insulin dose are also at increased risk. Monitor your ketone levels as directed by your doctor, and consult with them if you have any questions.
This medication may increase the risk of bone fractures. Discuss this potential risk with your doctor. Kidney problems and severe urinary tract infections (UTIs) have been reported, and in some cases, hospitalization may be necessary. Kidney problems may require dialysis.
If you are 65 years or older, use this medication with caution, as you may be more susceptible to side effects. Women of childbearing age who have not been ovulating may experience a return of fertility while taking this medication. To avoid pregnancy, use birth control while taking this drug. If you become pregnant or suspect you may be pregnant while taking this medication, contact your doctor immediately, as it may harm the unborn baby.
Overdose Information
Overdose Symptoms:
- Lactic acidosis (severe)
- Severe hypoglycemia (if co-administered with insulin/sulfonylurea)
- Severe dehydration
- Hypotension
- Renal failure
What to Do:
Contact a poison control center or emergency room immediately. Call 1-800-222-1222. Treatment is supportive and symptomatic. Hemodialysis can remove metformin and canagliflozin.
Drug Interactions
Contraindicated Interactions
- Iodinated contrast media (for metformin component - temporarily discontinue Invokamet at the time of or prior to the procedure in patients with an eGFR between 30 and 60 mL/min/1.73 m2, in patients with a history of liver disease, alcoholism, or heart failure, or in patients who will be administered intra-arterial iodinated contrast. Re-evaluate eGFR 48 hours after the procedure; restart Invokamet if renal function is stable.)
Major Interactions
- Alcohol (increased risk of lactic acidosis with metformin)
- Diuretics (loop or thiazide - increased risk of volume depletion and hypotension with canagliflozin)
- Digoxin (canagliflozin may increase digoxin exposure)
- UGT enzyme inducers (e.g., rifampin, phenytoin, phenobarbital, ritonavir - may decrease canagliflozin exposure)
- Carbonic anhydrase inhibitors (e.g., topiramate, zonisamide, acetazolamide, dichlorphenamide - increased risk of lactic acidosis with metformin)
Moderate Interactions
- Insulin and insulin secretagogues (e.g., sulfonylureas - increased risk of hypoglycemia when co-administered with canagliflozin or metformin)
- Drugs that reduce metformin clearance (e.g., cimetidine, ranolazine, dolutegravir, isavuconazole, trimethoprim, vandetanib - may increase metformin levels)
- Lithium (SGLT2 inhibitors may decrease lithium levels)
Minor Interactions
- Not available
Monitoring
Baseline Monitoring
Rationale: To assess baseline kidney function and determine appropriate dosing, as both components are renally cleared and contraindicated in severe renal impairment.
Timing: Prior to initiation of therapy.
Rationale: To establish baseline glycemic control.
Timing: Prior to initiation of therapy.
Rationale: To assess for baseline acid-base status, relevant for lactic acidosis risk with metformin.
Timing: Prior to initiation of therapy.
Routine Monitoring
Frequency: At least annually; more frequently (e.g., 2-4 times per year) in patients with eGFR <60 mL/min/1.73 m2, elderly, or those at risk for renal impairment.
Target: >60 mL/min/1.73 m2 for full dose; >45 mL/min/1.73 m2 for reduced canagliflozin dose; >30 mL/min/1.73 m2 for any use.
Action Threshold: Discontinue if eGFR falls persistently below 45 mL/min/1.73 m2 (canagliflozin) or 30 mL/min/1.73 m2 (metformin).
Frequency: Every 3-6 months.
Target: Individualized, typically <7% for most adults.
Action Threshold: Re-evaluate therapy if target not met.
Frequency: Daily (self-monitoring) or as clinically indicated.
Target: Individualized, e.g., FPG 80-130 mg/dL, postprandial <180 mg/dL.
Action Threshold: Adjust therapy based on trends and patient symptoms.
Frequency: Ongoing clinical assessment.
Target: N/A
Action Threshold: Promptly evaluate and discontinue if suspected.
Frequency: Periodically (e.g., every 1-2 years) for patients on long-term metformin therapy, especially those with risk factors for deficiency.
Target: Normal range.
Action Threshold: Supplement if deficient.
Symptom Monitoring
- Signs of lactic acidosis (malaise, myalgia, respiratory distress, somnolence, abdominal distress, hypothermia, hypotension)
- Signs of dehydration/volume depletion (dizziness, lightheadedness, orthostatic hypotension)
- Symptoms of urinary tract infection (dysuria, frequent urination, urgency, fever, flank pain)
- Symptoms of genital mycotic infection (itching, discharge, irritation, rash in genital area)
- Symptoms of diabetic ketoacidosis (nausea, vomiting, abdominal pain, excessive thirst, rapid deep breathing, unusual sleepiness)
- Symptoms of hypoglycemia (sweating, tremor, confusion, hunger, irritability, dizziness, rapid heartbeat)
- Symptoms of Fournier's gangrene (tenderness, redness, or swelling in the genital or perineal area, accompanied by fever or malaise)
- New pain, tenderness, sores, ulcers, or infections in the legs or feet (for lower limb amputation risk with canagliflozin)
Special Patient Groups
Pregnancy
Not recommended during the second and third trimesters of pregnancy due to potential adverse renal effects on the developing fetus (canagliflozin). Metformin is generally considered safer in pregnancy for type 2 diabetes or gestational diabetes, but the combination product carries the risk of canagliflozin.
Trimester-Specific Risks:
Lactation
Not recommended. Both canagliflozin and metformin are excreted into breast milk. Due to the potential for serious adverse reactions in a breastfed infant, a decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.
Pediatric Use
Safety and effectiveness of Invokamet have not been established in pediatric patients. Not recommended for use in patients younger than 18 years of age.
Geriatric Use
Increased risk of renal impairment, volume depletion, and lactic acidosis. Renal function should be assessed more frequently in elderly patients. Exercise caution when prescribing to patients 65 years or older, especially those with eGFR <60 mL/min/1.73 m2.
Clinical Information
Clinical Pearls
- Invokamet should be taken with meals to minimize the gastrointestinal side effects associated with metformin.
- Patients should be educated on the signs and symptoms of lactic acidosis, DKA, UTIs, and genital mycotic infections, and instructed to seek immediate medical attention if these occur.
- Prior to initiation, assess renal function (eGFR) and monitor periodically, as dose adjustments or discontinuation are required based on eGFR.
- Temporarily discontinue Invokamet for procedures requiring iodinated contrast media, surgery, or other conditions that may predispose to hypovolemia, hypotension, or renal impairment.
- Be aware of the increased risk of lower limb amputation with canagliflozin; monitor patients for new pain, tenderness, sores, ulcers, or infections in the legs or feet.
- Consider periodic vitamin B12 level monitoring in patients on long-term metformin therapy, especially those with risk factors for deficiency.
Alternative Therapies
- Other SGLT2 inhibitors (e.g., Invokana, Farxiga, Jardiance)
- Other biguanides (Metformin monotherapy)
- DPP-4 inhibitors (e.g., Januvia, Tradjenta)
- GLP-1 receptor agonists (e.g., Ozempic, Trulicity)
- Sulfonylureas (e.g., Glipizide, Glyburide)
- Thiazolidinediones (e.g., Pioglitazone)
- Insulin